Early behavioral screening for antidepressants and anxiolytics-

Authors
V. Castagné, R. D. Porsolt, P. Moser.


Lab
Porsolt & Partners Pharmacology, Boulogne-Billancourt, France

Journal
Drug Development Research

Abstract
Early preclinical behavioral testing is an essential stage during the development of substances with potential antidepressant and/or anxiolytic activity. With the growing cost of drug development, optimal research strategies are needed to detect potential new treatments with high efficacy and minimal side effects and to confirm in vitro pharmacological studies. In the following article, we present simple rodent tests used for early behavioral testing for antidepressant-like and anxiolytic-like activity. Unpublished results from our laboratory are discussed with reference to published data to illustrate the predictive validity of several behavioral screening tests.

BIOSEB Instruments Used:
Tail Suspension Test - Wireless (BIO-TST5)

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.